Literature DB >> 22981865

Tet2 facilitates the derepression of myeloid target genes during CEBPα-induced transdifferentiation of pre-B cells.

Eric M Kallin1, Javier Rodríguez-Ubreva, Jesper Christensen, Luisa Cimmino, Iannis Aifantis, Kristian Helin, Esteban Ballestar, Thomas Graf.   

Abstract

The methylcytosine hydroxylase Tet2 has been implicated in hematopoietic differentiation and the formation of myeloid malignancies when mutated. An ideal system to study the role of Tet2 in myelopoeisis is CEBPα-induced transdifferentiation of pre-B cells into macrophages. Here we found that CEBPα binds to upstream regions of Tet2 and that the gene becomes activated. Tet2 knockdowns impaired the upregulation of macrophage markers as well as phagocytic capacity, suggesting that the enzyme is required for both early and late stage myeloid differentiation. A slightly weaker effect was seen in primary cells with a Tet2 ablation. Expression arrays of transdifferentiating cells with Tet2 knockdowns permitted the identification of a small subset of myeloid genes whose upregulation was blunted. Activation of these target genes was accompanied by rapid increases of promoter hydroxy-methylation. Our observations indicate that Tet2 helps CEBPα rapidly derepress myeloid genes during the conversion of pre-B cells into macrophages.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981865      PMCID: PMC3667550          DOI: 10.1016/j.molcel.2012.08.007

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  42 in total

1.  Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain.

Authors:  Junjie U Guo; Yijing Su; Chun Zhong; Guo-li Ming; Hongjun Song
Journal:  Cell       Date:  2011-04-14       Impact factor: 41.582

2.  DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction.

Authors:  Ann-Marie Bröske; Lena Vockentanz; Shabnam Kharazi; Matthew R Huska; Elena Mancini; Marina Scheller; Christiane Kuhl; Andreas Enns; Marco Prinz; Rudolf Jaenisch; Claus Nerlov; Achim Leutz; Miguel A Andrade-Navarro; Sten Eirik W Jacobsen; Frank Rosenbauer
Journal:  Nat Genet       Date:  2009-10-04       Impact factor: 38.330

3.  A robust and highly efficient immune cell reprogramming system.

Authors:  Lars H Bussmann; Alexis Schubert; Thien Phong Vu Manh; Luisa De Andres; Sabrina C Desbordes; Maribel Parra; Timo Zimmermann; Francesca Rapino; Javier Rodriguez-Ubreva; Esteban Ballestar; Thomas Graf
Journal:  Cell Stem Cell       Date:  2009-11-06       Impact factor: 24.633

4.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.

Authors:  Cyril Quivoron; Lucile Couronné; Véronique Della Valle; Cécile K Lopez; Isabelle Plo; Orianne Wagner-Ballon; Marcio Do Cruzeiro; Francois Delhommeau; Bertrand Arnulf; Marc-Henri Stern; Lucy Godley; Paule Opolon; Hervé Tilly; Eric Solary; Yannis Duffourd; Philippe Dessen; Hélène Merle-Beral; Florence Nguyen-Khac; Michaëla Fontenay; William Vainchenker; Christian Bastard; Thomas Mercher; Olivier A Bernard
Journal:  Cancer Cell       Date:  2011-06-30       Impact factor: 31.743

5.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.

Authors:  Kelly Moran-Crusio; Linsey Reavie; Alan Shih; Omar Abdel-Wahab; Delphine Ndiaye-Lobry; Camille Lobry; Maria E Figueroa; Aparna Vasanthakumar; Jay Patel; Xinyang Zhao; Fabiana Perna; Suveg Pandey; Jozef Madzo; Chunxiao Song; Qing Dai; Chuan He; Sherif Ibrahim; Miloslav Beran; Jiri Zavadil; Stephen D Nimer; Ari Melnick; Lucy A Godley; Iannis Aifantis; Ross L Levine
Journal:  Cancer Cell       Date:  2011-06-30       Impact factor: 31.743

Review 6.  Active DNA demethylation: many roads lead to Rome.

Authors:  Susan C Wu; Yi Zhang
Journal:  Nat Rev Mol Cell Biol       Date:  2010-08-04       Impact factor: 94.444

7.  Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells.

Authors:  Kian Peng Koh; Akiko Yabuuchi; Sridhar Rao; Yun Huang; Kerrianne Cunniff; Julie Nardone; Asta Laiho; Mamta Tahiliani; Cesar A Sommer; Gustavo Mostoslavsky; Riitta Lahesmaa; Stuart H Orkin; Scott J Rodig; George Q Daley; Anjana Rao
Journal:  Cell Stem Cell       Date:  2011-02-04       Impact factor: 24.633

8.  Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine.

Authors:  Seung-Gi Jin; Swati Kadam; Gerd P Pfeifer
Journal:  Nucleic Acids Res       Date:  2010-04-05       Impact factor: 16.971

9.  Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

Authors:  Maria E Figueroa; Omar Abdel-Wahab; Chao Lu; Patrick S Ward; Jay Patel; Alan Shih; Yushan Li; Neha Bhagwat; Aparna Vasanthakumar; Hugo F Fernandez; Martin S Tallman; Zhuoxin Sun; Kristy Wolniak; Justine K Peeters; Wei Liu; Sung E Choe; Valeria R Fantin; Elisabeth Paietta; Bob Löwenberg; Jonathan D Licht; Lucy A Godley; Ruud Delwel; Peter J M Valk; Craig B Thompson; Ross L Levine; Ari Melnick
Journal:  Cancer Cell       Date:  2010-12-09       Impact factor: 38.585

10.  Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.

Authors:  Myunggon Ko; Yun Huang; Anna M Jankowska; Utz J Pape; Mamta Tahiliani; Hozefa S Bandukwala; Jungeun An; Edward D Lamperti; Kian Peng Koh; Rebecca Ganetzky; X Shirley Liu; L Aravind; Suneet Agarwal; Jaroslaw P Maciejewski; Anjana Rao
Journal:  Nature       Date:  2010-12-09       Impact factor: 49.962

View more
  51 in total

1.  TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.

Authors:  F Neri; D Dettori; D Incarnato; A Krepelova; S Rapelli; M Maldotti; C Parlato; P Paliogiannis; S Oliviero
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

2.  Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis.

Authors:  Ruili Yang; Cunye Qu; Yu Zhou; Joanne E Konkel; Shihong Shi; Yi Liu; Chider Chen; Shiyu Liu; Dawei Liu; Yibu Chen; Ebrahim Zandi; Wanjun Chen; Yanheng Zhou; Songtao Shi
Journal:  Immunity       Date:  2015-08-11       Impact factor: 31.745

3.  The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.

Authors:  Su Jung Song; Keisuke Ito; Ugo Ala; Lev Kats; Kaitlyn Webster; Su Ming Sun; Mojca Jongen-Lavrencic; Katia Manova-Todorova; Julie Teruya-Feldstein; David E Avigan; Ruud Delwel; Pier Paolo Pandolfi
Journal:  Cell Stem Cell       Date:  2013-07-03       Impact factor: 24.633

4.  Short-term memory of danger signals and environmental stimuli in immune cells.

Authors:  Silvia Monticelli; Gioacchino Natoli
Journal:  Nat Immunol       Date:  2013-08       Impact factor: 25.606

Review 5.  TET2: A Novel Epigenetic Regulator and Potential Intervention Target for Atherosclerosis.

Authors:  Yami Liu; Wen Peng; Kai Qu; Xiaolong Lin; Zhaolin Zeng; Jiaojiao Chen; Dangheng Wei; Zuo Wang
Journal:  DNA Cell Biol       Date:  2018-04-13       Impact factor: 3.311

6.  An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis.

Authors:  Jijun Cheng; Shangqin Guo; Suning Chen; Stephen J Mastriano; Chaochun Liu; Ana C D'Alessio; Eriona Hysolli; Yanwen Guo; Hong Yao; Cynthia M Megyola; Dan Li; Jun Liu; Wen Pan; Christine A Roden; Xiao-Ling Zhou; Kartoosh Heydari; Jianjun Chen; In-Hyun Park; Ye Ding; Yi Zhang; Jun Lu
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

7.  Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation.

Authors:  Abhishek Sohni; Michela Bartoccetti; Rita Khoueiry; Lien Spans; Joris Vande Velde; Linde De Troyer; Kirthi Pulakanti; Frank Claessens; Sridhar Rao; Kian Peng Koh
Journal:  Mol Cell Biol       Date:  2015-01-12       Impact factor: 4.272

Review 8.  Epigenetic control of myeloid cell differentiation, identity and function.

Authors:  Damiana Álvarez-Errico; Roser Vento-Tormo; Michael Sieweke; Esteban Ballestar
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

Review 9.  DNA methylation and methylcytosine oxidation in cell fate decisions.

Authors:  Kian Peng Koh; Anjana Rao
Journal:  Curr Opin Cell Biol       Date:  2013-03-14       Impact factor: 8.382

Review 10.  Epigenetic regulation of smooth muscle cell plasticity.

Authors:  Renjing Liu; Kristen L Leslie; Kathleen A Martin
Journal:  Biochim Biophys Acta       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.